Review



rabbit polyclonal anti bub1b  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech rabbit polyclonal anti bub1b
    Rabbit Polyclonal Anti Bub1b, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti bub1b/product/Proteintech
    Average 94 stars, based on 29 article reviews
    rabbit polyclonal anti bub1b - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    rabbit polyclonal anti bub1b  (Proteintech)
    94
    Proteintech rabbit polyclonal anti bub1b
    Rabbit Polyclonal Anti Bub1b, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti bub1b/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti bub1b - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    rabbit polyclonal anti bub1b antibody  (Proteintech)
    94
    Proteintech rabbit polyclonal anti bub1b antibody
    Top 10 Hub Genes With Higher Degree Scores.
    Rabbit Polyclonal Anti Bub1b Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti bub1b antibody/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti bub1b antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Top 10 Hub Genes With Higher Degree Scores.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Top 10 Hub Genes With Higher Degree Scores.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques: Protein Binding, Binding Assay, Activity Assay, Transduction, Ubiquitin Proteomics, Phospho-proteomics

    Correlation between methylation levels and cancer-testis (CT) gene expression. Promoter methylation and gene expression data from The Cancer Genome Atlas (TCGA) were visualized using cBioPortal to demonstrate the correlation among selected hub CT genes, and significant negative relationship was identified in: (A) ARUKA, (B) ASPM, (C) BUB1, (D) BUB1B, (E) CCNB2, (F) NUF2, (G) PBK, (H) TPX2.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Correlation between methylation levels and cancer-testis (CT) gene expression. Promoter methylation and gene expression data from The Cancer Genome Atlas (TCGA) were visualized using cBioPortal to demonstrate the correlation among selected hub CT genes, and significant negative relationship was identified in: (A) ARUKA, (B) ASPM, (C) BUB1, (D) BUB1B, (E) CCNB2, (F) NUF2, (G) PBK, (H) TPX2.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques: Methylation, Gene Expression

    Prognostic values of 9 cancer-testis (CT) genes identified by overall survival analysis using Kaplan-Meier curve from GEPIA: (A) ASPM, (B) ARUKA, (C) BUB1, (D) BUB1B, (E) CDC45, (F) DLGAP5, (G) NUF2, (H) PBK, (I) TPX2.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Prognostic values of 9 cancer-testis (CT) genes identified by overall survival analysis using Kaplan-Meier curve from GEPIA: (A) ASPM, (B) ARUKA, (C) BUB1, (D) BUB1B, (E) CDC45, (F) DLGAP5, (G) NUF2, (H) PBK, (I) TPX2.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques:

    BUB1B might be a potential target for immunotherapy in hepatocellular carcinoma (HCC). (A) Association of the BUB1B expression and CD8 + T-cell infiltration in HCC by TISIDB (r = −0.129, P = .013). (B) BUB1B expression level is negatively associated with CD8 + T-cell infiltration level validated in our 72 patients, tested by Spearman test (r = −0.489, P < .001). (C) Representative immunohistochemical staining of BUB1B, β-catenin, and CD8 in HCC. Negative, weak positive, moderate positive, and strong positive expression of BUB1B were shown, respectively. (D) Association of the BUB1B messenger RNA (mRNA) expression and β-catenin mRNA in HCC by GEPIA (r = 0.46, P < .001). (E) BUB1B expression level is positively associated with β-catenin expression level validated in our 72 patients, tested by Spearman test (r = −0.588, P < .001). (F) Overall survival (OS) curves of patients with HCC according to cancer expressed BUB1B levels ( P < .001). (G) Disease-free survival (DFS) curves of patients with HCC according to cancer expressed BUB1B levels ( P = .008).

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: BUB1B might be a potential target for immunotherapy in hepatocellular carcinoma (HCC). (A) Association of the BUB1B expression and CD8 + T-cell infiltration in HCC by TISIDB (r = −0.129, P = .013). (B) BUB1B expression level is negatively associated with CD8 + T-cell infiltration level validated in our 72 patients, tested by Spearman test (r = −0.489, P < .001). (C) Representative immunohistochemical staining of BUB1B, β-catenin, and CD8 in HCC. Negative, weak positive, moderate positive, and strong positive expression of BUB1B were shown, respectively. (D) Association of the BUB1B messenger RNA (mRNA) expression and β-catenin mRNA in HCC by GEPIA (r = 0.46, P < .001). (E) BUB1B expression level is positively associated with β-catenin expression level validated in our 72 patients, tested by Spearman test (r = −0.588, P < .001). (F) Overall survival (OS) curves of patients with HCC according to cancer expressed BUB1B levels ( P < .001). (G) Disease-free survival (DFS) curves of patients with HCC according to cancer expressed BUB1B levels ( P = .008).

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques: Expressing, Immunohistochemical staining, Staining

    Clinical and Pathological Features of the 72 Patients.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Clinical and Pathological Features of the 72 Patients.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques:

    Univariate and Multivariate Analyses of Clinicopathologic Factors in Patients With HCC With Respect to OS.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Univariate and Multivariate Analyses of Clinicopathologic Factors in Patients With HCC With Respect to OS.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques:

    Univariate and Multivariate Analyses of Clinicopathologic Factors in Patients With HCC With Respect to DFS.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy

    doi: 10.1177/1533033820944274

    Figure Lengend Snippet: Univariate and Multivariate Analyses of Clinicopathologic Factors in Patients With HCC With Respect to DFS.

    Article Snippet: Primary antibodies used for immunohistochemistry (IHC) of paraffin-embedded 72 HCC tissues and their paired noncancerous tissues included rabbit polyclonal anti-BUB1B antibody (1:200, Proteintech, Cat No. 11504-2-AP), rabbit polyclonal anti-ASPM antibody (1:100, Proteintech, Cat No. 26223-1-AP), rabbit polyclonal anti-beta catenin antibody (1:2000, Proteintech, Cat No. 51067-2-AP), and mouse monoclonal anti-CD8 antibody (1:200, Abcam, Cat No. ab17147).

    Techniques: